This included brain disease traits with expression in the nervous system (antisense to APP and two antisense lncRNAs to MAPT) as well as immune-related diseases and enrichment in immune cells (antisense to LRRK2 and C9orf72). This evidence concerns the gene LRRK2 and brain disorder.